Thermo Fisher’s Oncomine gains FDA approval as brain tumor diagnostic
As a companion diagnostic, Oncomine will be used to identify patients eligible for treatment with Servier’s Voranigo.
Device Development
Amgen and MSD-backed start-up wins $10m for drug and device development
New UK intracellular drug delivery centre to support RNA development
Pharmaceutical Technology Excellence Awards 2022: NTI – Northgate Technologies
When is a drug a device?
bit.bio raises $103m through series B round to develop cell therapies
Pfizer and Voyager Therapeutics sign $630m gene therapy deal
Biologics packaging: unwrapping a complex challenge
